MedMined® Surveillance Advisor Wins 2015/2016 KLAS Category Leader Award
Marks sixth year in top spot for infection control and monitoring category
Mar 15, 2016
FRANKLIN LAKES, N.J., March 15, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that BD MedMined® Surveillance Advisor has been named a 2015/2016 Category Leader for Infection Control and Monitoring in the 2015/2016 Best in KLAS: Software and Service report, based on customer feedback.
This award marks the sixth year that MedMined Surveillance Advisor has finished first in the Infection Control and Monitoring category by KLAS, a company that independently monitors health care information technology performance through the active participation of thousands of users of the products and services. The award was presented February 29 at the Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition in Las Vegas.
“We are honoureded that hospitals and infection prevention professionals have once again ranked MedMined Surveillance Advisor as the best technology for Infection Control and Monitoring,” said Bert Williams, vice president and general manager of MedMined Services for BD. “The MedMined approach streamlines infection monitoring, optimises clinical staff workflow and fosters an integrated antimicrobial stewardship programme for infection preventionists, pharmacists and physicians.”
MedMined Surveillance Advisor provides automated infection surveillance and data mining proven to help hospitals identify and reduce health care associated infections (HAIs) and antimicrobial resistance. With its patented algorithm supporting the early detection of patterns of emerging pathogens, the infection prevention team is empowered to efficiently focus resources on developing trends in HAIs and multiple-drug resistant organisms. The combined surveillance package of alerts, reports, training and consulting services allows for more time to be spent on clinical intervention and patient care.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
For more information on BD, please visit bd.com.
Monique N. Dolecki
201 847 5378
Back to News Releases
Please note, products and services mentioned may not be licensed/available in Canada. Please check with your local BD representative.